Pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulations, Alkem Laboratories has informed that the Company has received an order passed by statutory authority under the Goods and Services Tax Act, 2017 and the details as required under Clause 20 of Para A of Part A of Schedule III of SEBI LODR Regulations is enclosed as Annexure A. The Company is in the process of taking appropriate action(s), including but not limited to the filing of an appeal against the order. The above information is also available on the website of the Company at www.alkemlabs.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: